Latus Bio

Latus Bio is a biotechnology company focused on developing gene therapy candidates using Adeno-Associated Virus (AAV) vectors to target diseases of the central nervous system and the periphery. The company engineers novel AAV capsid variants and optimizes delivery methods to improve the precision of gene transfer to specific tissues and cell types. Gene therapy approaches at Latus Bio emphasize reducing dose requirements while addressing challenges such as toxicity, manufacturing complexity, and inconsistent efficacy associated with traditional AAV therapies.